J. Tagat
{"title":"CCR5 Antagonists: Small‐Molecule Inhibitors For Blocking HIV‐1 Entry","authors":"J. Tagat","doi":"10.1002/0471266949.BMC230","DOIUrl":null,"url":null,"abstract":"First page of article \n \n \nKeywords: \n \nCCR5 antagonists; \nblocking HIV-1 entry; \nsmall-molecule inhibitors","PeriodicalId":9514,"journal":{"name":"Burger's Medicinal Chemistry and Drug Discovery","volume":"56 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2010-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Burger's Medicinal Chemistry and Drug Discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/0471266949.BMC230","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
CCR5拮抗剂:阻断HIV - 1进入的小分子抑制剂
论文第一页关键词:CCR5拮抗剂;阻断HIV-1进入;小分子抑制剂
本文章由计算机程序翻译,如有差异,请以英文原文为准。